| |
| |
|
| Insider
Information: |
Lee Yuchun |
| Relationship: |
Director |
| City: |
Waltham |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,875 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$834,769 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,875 |
|
|
| Total
Value |
$834,769 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Unica Corp |
UNCA |
President, CEO & Chair... |
2010-10-05 |
0 |
2010-10-05 |
0 |
Premium* |
|
|
Vertex Pharmaceuticals Inc |
VRTX |
Director |
2023-01-27 |
1,875 |
2015-09-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
152 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| UNCA |
Unica Corp |
President, CEO & Chairman |
• • • |
2010-10-05 |
4 |
D |
$21.00 |
$91,575,918 |
I/I |
(4,360,758) |
0 |
0 |
- |
|
| UNCA |
Unica Corp |
President, CEO & Chairman |
• • • |
2010-10-05 |
4 |
D |
$21.00 |
$1,094,184 |
D/D |
(52,104) |
0 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2015-09-01 |
4 |
AS |
$123.92 |
$141,070 |
D/D |
(1,125) |
208 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2015-10-01 |
4 |
AS |
$102.80 |
$117,716 |
D/D |
(1,125) |
416 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2015-11-02 |
4 |
AS |
$123.64 |
$141,967 |
D/D |
(1,125) |
625 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2015-12-01 |
4 |
AS |
$128.77 |
$145,860 |
D/D |
(1,125) |
833 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2020-02-03 |
4 |
AS |
$229.39 |
$462,196 |
D/D |
(2,000) |
847 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2016-01-04 |
4 |
AS |
$122.07 |
$137,489 |
D/D |
(1,125) |
1,041 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2015-09-01 |
4 |
OE |
$57.27 |
$76,341 |
D/D |
1,333 |
1,333 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2015-10-01 |
4 |
OE |
$57.27 |
$76,341 |
D/D |
1,333 |
1,541 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2015-11-02 |
4 |
OE |
$57.27 |
$76,398 |
D/D |
1,334 |
1,750 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2020-02-04 |
4 |
AS |
$235.15 |
$477,672 |
D/D |
(2,000) |
1,875 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2020-02-05 |
4 |
AS |
$240.59 |
$484,763 |
D/D |
(2,000) |
1,875 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2020-02-06 |
4 |
AS |
$238.71 |
$479,017 |
D/D |
(2,000) |
1,875 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2020-02-07 |
4 |
AS |
$234.84 |
$475,643 |
D/D |
(2,000) |
1,875 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2020-02-10 |
4 |
AS |
$240.04 |
$286,403 |
D/D |
(1,181) |
1,875 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2020-04-20 |
4 |
AS |
$269.97 |
$546,310 |
D/D |
(2,000) |
1,875 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2020-04-21 |
4 |
AS |
$263.20 |
$533,523 |
D/D |
(2,000) |
1,875 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2020-04-22 |
4 |
AS |
$265.16 |
$535,753 |
D/D |
(2,000) |
1,875 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2020-04-23 |
4 |
AS |
$267.47 |
$545,052 |
D/D |
(2,000) |
1,875 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2020-04-24 |
4 |
AS |
$267.23 |
$536,286 |
D/D |
(2,000) |
1,875 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2020-04-27 |
4 |
AS |
$268.40 |
$542,419 |
D/D |
(2,000) |
1,875 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2020-04-28 |
4 |
AS |
$254.81 |
$290,115 |
D/D |
(1,125) |
1,875 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2022-04-04 |
4 |
AS |
$265.83 |
$535,431 |
D/D |
(2,000) |
1,875 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
Director |
– • – |
2022-04-05 |
4 |
AS |
$268.30 |
$544,993 |
D/D |
(2,000) |
1,875 |
0 |
% |
|
152 Records found
|
|
Page 1 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
